Terms: = Ovarian cancer AND PBX1, P40424, 5087 AND Treatment
4 results:
1. Disease-inducing potential of two leukemic cell lines in a xenografting model.
Manavella DD; Herraiz S; Soares M; Buigues A; Pellicer A; Donnez J; Díaz-García C; Dolmans MM
J Assist Reprod Genet; 2021 Jun; 38(6):1589-1600. PubMed ID: 33786735
[TBL] [Abstract] [Full Text] [Related]
2. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-pbx1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract] [Full Text] [Related]
3. ovarian cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor pbx1.
Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
[TBL] [Abstract] [Full Text] [Related]